renin
美 
英 ['riːnɪn]
- n.【生化】肾素；高血压蛋白原酶
- 网络肾活素；血管紧张肽原酶；肾酵素
英汉解释
英英解释
例句
Their results revealed that the protein is oxidised and changes shape to permit ready access to angiotensinogen by an enzyme, renin.
结果显示这种蛋白被一种叫肾素的酶氧化后改变形态以接近血管紧张素原。
Direct renin inhibitionwithaliskiren therefore represents an effective option for the long-term treatment ofessentialhypertension.
直接肾素抑制剂阿利吉仑可以坐位原发性高血压长期治疗的有效选择。
Plasma renin activity; Aldosterone; Malignant hypertensive arteriolar nephrosclerosis; Diagnosis.
血浆肾素活性；醛固酮；恶性高血压性小动脉性肾硬化；诊断。
Inhibitors of the renin-angiotensin-aldosterone system may reduce LV mass to a greater extent than other antihypertensive agents.
与其它抗高血压药物相比，肾素-血管紧张素-醛固酮系统抑制剂可以明显减低左室重量。
The influence of contrast material on renal venous renin activity was evaluated in a prospective study of 20 hypertensive patients .
我们对20例高血压患者作了前瞻性研究，以评定造影剂对肾静脉肾素活性的影响。
Renin cuts off the tail of the protein to release the hormone angiotensin, which then raises blood pressure.
肾素切断该蛋白的尾巴以释放血管紧张素，使血压升高。
It blocks that part of the renin-angiotensin-aldosterone hormonal system that narrows (constricts) the peripheral arteries.
一方面，它可以阻断肾素-血管紧缩素-醛固酮的激素系统，该系统会引起周围动脉的狭窄。
International Circulation: What about direct renin inhibition and its effect on cardiorenal protection?
《国际循环》：直接的肾素抑制剂是如何发挥心肾保护作用的？
Aliskiren represents a new principle of blocking the RAAS, inhibiting renin directly and acting at the rate-limiting step.
阿利吉仑代表一种阻滞RAAS的新原理，直接抑制肾素并作用于限速阶段。
Genes may be involved in the renin and angiotensin system, insulin resistance, sodium sensitivity, and body weight.
可能有关的基因牵涉到肾素与血管紧张素系统、对胰岛素抗拒、对钠敏感、以及体重。
Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
心肌梗死患者干预肾素-血管紧张素系统药物治疗的新选择？
This study investigates aliskiren, the first in a new antihypertensive class called renin inhibitors.
本试验中所研究的阿利克伦是新一类降压药-肾素抑制剂的首种药物。
Lower-sodium diets also boosted levels of the hormones renin and aldosterone, which can raise blood pressure.
低盐饮食也能够增加可以提高血压的肾素水平和醛固酮水平。
When you combine an ACE inhibitor B, the plasma renin activity increases so much.
当联合使用一种ACE抑制剂时，血浆肾素活性增强是如此之大。
The mechanisms of pharmacologic blockade of the renin-angiotensin system are discussed.
药理机制的封锁肾素血管紧张素系统进行了讨论。
The renin-angiotensin-aldosterone system (RAAS) is a feedback system activated with volume depletion.
肾素-血管紧张素-醛固酮系统（RAAS）是一种能被容量丢失激活的反馈控制系统。
Hypertension is more likely to be accompanied by low renin levels in blacks and the elderly.
在黑人和老年高血压患者中，更可能伴有低肾素水平。
The renin-angiotensin-aldosterone system plays an important role in regulating the circadian rhythms of blood pressure.
肾素-血管紧张素-醛固酮系统在血压昼夜节律的调节中起着关键作用。
through renin - angiotensin system regulating blood pressure.
通过肾素-血管紧张素系统调节血压。
The existence of a brain renin-angiotensin system (RAS) was postulated 30 years ago.
存在一个脑肾素血管紧张素系统（RAS）是假设30年前。
Previous studies have suggested that the renin-angiotensin system plays a role in body fat and obesity.
早先的研究已经提示肾素-血管紧张素系统在机体脂肪（蓄积）和肥胖方面发挥作用。
The synthesis and secretion of active renin were regulated by progesterone in incubated decidual cells.
孕酮可调节蜕膜细胞活性肾素的合成与分泌。
The status of renin-angiotensin system inhibitors as the first-line drug has become established in high-risk patients.
对肾素血管紧张素系统抑制剂作为一线药物的地位已成为高风险患者建立。
This talk will address the principle of renin inhibition, taking into consideration the role of prorenin and the (pro)renin receptor.
此文简述了肾素抑制的原理，同时也将肾素原和肾素（肾素原）受体考虑其中。
Renin inhibitors will block such prorenin-induced angiotensin generation.
肾素抑制剂能阻止肾素原诱导产生高血压素（血管紧张素）。
The mechanism by which they block the renin- angiotensin system is different.
这种药物阻断肾素-血管紧张素系统的机制不同于其他药物。
The urinary protein reduction was observed only in patients with renin-angiotensin inhibition (p=0. 0216).
只在使用血管紧张素的患者中发现尿蛋白的降低（p=0.0216）。
This structure is the site for renin production.
此结构是产生肾素的部位。
The pathways have a great deal in common and we know that the renin-angiotensin system is critical at various steps in these pathways.
这些途径有很多共通之处，我们知道，肾素-血管紧张素系统在这些途径的各个步骤中起到关键作用。
Renin inhibitor. And we have more new drugs is under investigating.
肾素抑制剂。也有很多新药在进行研究。
Objective To explore the association between activity of renin-angiotensin system and essential hypertension in Mongolian people in China.
目的探讨蒙古族人血浆肾素-血管紧张素系统的活性与原发性高血压的关系。
The plasma-aldosterone-to-renin ratio is used as a screening test.
血浆醛固酮对肾素比值是用作筛选试验。
The human body, for example, uses the hormones renin, angiotensin, and aldosterone to retain or release tissue fluids and blood plasma.
例如，人体为了保留或释放组织液体和血浆而使用高血压蛋白原酶、血管紧张素、醛固酮等激素。
Objective To study the effect of the local renin-angiotensin-aldosterone system on myocardial fibrosis in diabetic rats.
目的初步探讨心肌局部肾素-血管紧张素-醛固酮系统在糖尿病大鼠心肌纤维化中的作用；
The Effect of Losartan and a Combination of Losartan and Hydrochlorothiazide on Plasma Renin Activity in Patients with Hypertension
氯沙坦及氯沙坦与双氢克尿噻合剂对原发性高血压患者肾素活性影响的比较
Changes of the activity of circulating renin - angiotensin - aldosterone system in patients with rheumatic mitral stenosis
风湿性心脏病二尖瓣狭窄患者血浆肾素-血管紧张素-醛固酮系统活性变化
Study of correlation between renal vein renin and therapeutic effect of percutaneous renal artery stenting
肾静脉肾素水平与肾动脉介入治疗疗效的相关性研究
Single Nucleotide Polymorphisms of Renin Gene and its Correlation with Myocardial Infarction
肾素基因单核苷酸多态与心肌梗死的关系
Gene expression changes of the local intracardiac renin-angiotensin system elements after myocardial ischemia
心肌缺血时大鼠离体心脏局部肾素-血管紧张素系统表达的变化
Relationship between renin-angiotensin system and angiotensin converting enzyme gene polymorphism
肾素-血管紧张素系统与血管紧张素转换酶基因多态性的关系
